Lab-on-a-Chip Technology Demonstrated in Small Diagnostic Device

The device can measure biomarkers with high sensitivity and at low cost.

The technology uses semiconductor films located on either side of a microfluidics chip. One film illuminates the chip, where appropriate, while the other film detects an output signal, which is fed to a display. The device used two forms of detection utilizing chemiluminescence and fluorescence to detect different markers of interest.

Developed by Acrongenomics (Geneva, Switzerland) and Molecular Vision (London, UK) this technology is capable of further miniaturization along with large scale, low cost manufacturing, which will bring forward disposable, point-of-care diagnostics for a large range of biomarkers. The companies presented possible design concepts of their BioLED Lab-on-a-Chip technology applications to be used at home, in doctor's offices, and hospitals.

Molecular Vision is a spin-out company of Imperial Innovations Ltd, and was founded in order to meet a clearly defined demand in the medical diagnostics, biosensors, and analytic instrumentations markets: the need for miniaturized chemical and biologic detectors offering high sensitivity and functionality at low cost. The company has directly addressed this market demand by inventing a novel method for optical detection based on recent advances in organic electronics and light-emitting diodes combined with microfluidics technology. The company has mainly focused on applying its technology to the medical diagnostics markets. Molecular Vision recently signed a major development contract with Acrongenomics, Inc., to jointly exploit and commercialize the technology.

Acrongenomics Inc. is a publicly traded company that focuses on investing in and commercializing novel technology platforms concerning the Life Sciences sector. Acrongenomics brings novel and realistic concepts to market by transforming scientific innovations into tangible, consumer-orientated applications.


Related Links:
Acrongenomics